AMH-MIS may be used in the investigation of ovarian reserve since AMH concentrations in adult women reflect the number of small antral and preantral follicles entering the growth phase of their life cycle. These follicles are proportional to the number of primordial follicles that still remain in the ovary, or the ovarian reserve.
AMH decreases throughout a woman's reproductive life, which reflects the continuous decline of the oocyte/follicle pool with age and, accordingly, ovarian aging.
Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
0.5 mL Serum from a Red Top Tube in a Plastic Vial
0.5 mL Plasma from a Green Top Tube, Li Heparin in a Plastic Vial
24 hours Ambient
6 days Refrigerated
28 days Frozen
0.3 mL Serum
| 0-17 years | Not established |
| 18-25 years | 1.02 -14.63 ng/mL |
| 26-30 years | 0.69-13.39 ng/mL |
| 31-35 years | 0.36-10.07 ng/mL |
| 36-40 years | 0.18-5.68 ng/mL |
| 41-45 years | 0.01-2.99 ng/mL |
| >45 years | Not established |
AMH-MIS may be used in the investigation of ovarian reserve since AMH concentrations in adult women reflect the number of small antral and preantral follicles entering the growth phase of their life cycle. These follicles are proportional to the number of primordial follicles that still remain in the ovary, or the ovarian reserve.
AMH decreases throughout a woman's reproductive life, which reflects the continuous decline of the oocyte/follicle pool with age and, accordingly, ovarian aging.
Laboratory Developed Testing
2 to 3 days
00919624
82166